Pharmazz Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 44

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $250K

  • Investors
  • 3

Pharmazz General Information

Description

Operator of a pharmaceutical company intended to focus on discovering, acquiring, developing, and commercializing therapeutics. The company's products include therapeutics for hypovolemic shock, postoperative pain, cardiac arrest, Alzheimer's disease, ischemic stroke, spinal cord injury, tumour diagnosis, diabetic ketoacidosis, and opioid tolerance, enabling hospitals to avail products for the diagnosis and treatment of clinical conditions that require critical care and hospital settings.

Contact Information

Website
www.pharmazz.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 50 West 75th Street
  • Suite 105
  • Willowbrook, IL 60527
  • United States
+1 (630)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Corporate Office
  • 50 West 75th Street
  • Suite 105
  • Willowbrook, IL 60527
  • United States
+1 (630)

Pharmazz Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmazz Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 28-Jul-2026 $250K Completed Generating Revenue
4. Later Stage VC (Series A) 11-Jun-2025 Completed Generating Revenue
3. Angel (individual) 31-Mar-2018 Completed Generating Revenue
2. Grant 20-Aug-2017 $426K Completed Generating Revenue
1. Grant 01-Jan-2017 $277K Completed Generating Revenue
To view Pharmazz’s complete valuation and funding history, request access »

Pharmazz Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-2
Series A-1
Series A 4,245,022 $0.000001 6% $5.89 $5.89 1x $5.89 4.25%
To view Pharmazz’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Pharmazz Patents

  • 60

    Total Documents Applications and Grants

  • Total Patents Families

  • 23

    Granted

  • 26

    Pending

  • Expiring in next 12 mo

Pharmazz Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260345725-A1 Method of treating or preventing diabetes using endothelin-b receptor agonist or salt thereof Pending 05-May-2025
WO-2026236116-A1 Method of treating or preventing diabetes using endothelin-b receptor agonist or salt thereof Pending 05-May-2025
AU-2025250556-A1 Lyophilized centhaquine citrate injection formulation and a method for the same Pending 04-Apr-2024
WO-2025212798-A1 Lyophilized centhaquine citrate injection formulation and a method for the same Pending 04-Apr-2024
AU-2023340725-A1 Lyophilized sovateltide-based injectable formulation and a process for preparation Pending 28-Jun-2023 A61K38/10
To view Pharmazz’s complete patent history, request access »

Pharmazz Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharmazz Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Keiretsu Forum Angel Group Minority
Sun Pharmaceutical Industries Corporation Minority
National Heart, Lung, and Blood Institute Government
To view Pharmazz’s complete investors history, request access »

Ready to get started?

Request a free trial

Pharmazz FAQs

  • When was Pharmazz founded?

    Pharmazz was founded in 2010.

  • Where is Pharmazz headquartered?

    Pharmazz is headquartered in Willowbrook, IL.

  • What is the size of Pharmazz?

    Pharmazz has 44 total employees.

  • What industry is Pharmazz in?

    Pharmazz’s primary industry is Pharmaceuticals.

  • Is Pharmazz a private or public company?

    Pharmazz is a Private company.

  • What is Pharmazz’s current revenue?

    The current revenue for Pharmazz is .

  • How much funding has Pharmazz raised over time?

    Pharmazz has raised $41M.

  • Who are Pharmazz’s investors?

    Keiretsu Forum, Sun Pharmaceutical Industries, and National Heart, Lung, and Blood Institute have invested in Pharmazz.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process